Nanobiotechnology and Biophysics Laboratories (NBL), Department of Experimental Medicine (DIMES), University of Genoa, Genoa, Italy; Nanoworld Institute Fondazione ELBA Nicolini (FEN), Pradalunga, Bergamo, Italy.
Nanobiotechnology and Biophysics Laboratories (NBL), Department of Experimental Medicine (DIMES), University of Genoa, Genoa, Italy; Nanoworld Institute Fondazione ELBA Nicolini (FEN), Pradalunga, Bergamo, Italy; School of Public Health, Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy.
Adv Protein Chem Struct Biol. 2014;95:163-91. doi: 10.1016/B978-0-12-800453-1.00005-1.
In order to overcome the difficulties and hurdles too much often encountered in crystallizing a protein with the conventional techniques, our group has introduced the innovative Langmuir-Blodgett (LB)-based crystallization, as a major advance in the field of both structural and functional proteomics, thus pioneering the emerging field of the so-called nanocrystallography or nanobiocrystallography. This approach uniquely combines protein crystallography and nanotechnologies within an integrated, coherent framework that allows one to obtain highly stable protein crystals and to fully characterize them at a nano- and subnanoscale. A variety of experimental techniques and theoretical/semi-theoretical approaches, ranging from atomic force microscopy, circular dichroism, Raman spectroscopy and other spectroscopic methods, microbeam grazing-incidence small-angle X-ray scattering to in silico simulations, bioinformatics, and molecular dynamics, has been exploited in order to study the LB-films and to investigate the kinetics and the main features of LB-grown crystals. When compared to classical hanging-drop crystallization, LB technique appears strikingly superior and yields results comparable with crystallization in microgravity environments. Therefore, the achievement of LB-based crystallography can have a tremendous impact in the field of industrial and clinical/therapeutic applications, opening new perspectives for personalized medicine. These implications are envisaged and discussed in the present contribution.
为了克服传统技术在蛋白质结晶中经常遇到的困难和障碍,我们小组引入了创新的基于 Langmuir-Blodgett(LB)的结晶技术,这是结构和功能蛋白质组学领域的重大进展,开创了所谓的纳米结晶学或纳米生物结晶学这一新兴领域。这种方法将蛋白质结晶学和纳米技术独特地结合在一个集成的、连贯的框架内,使我们能够获得高度稳定的蛋白质晶体,并在纳米和亚纳米尺度上对其进行全面表征。我们利用了各种实验技术和理论/半理论方法,包括原子力显微镜、圆二色性、拉曼光谱和其他光谱方法、微束掠入射小角 X 射线散射以及计算机模拟、生物信息学和分子动力学,来研究 LB 膜并研究 LB 生长晶体的动力学和主要特征。与经典的悬滴结晶相比,LB 技术具有明显的优势,并且可以得到与微重力环境下结晶相当的结果。因此,基于 LB 的结晶学的实现可以在工业和临床/治疗应用领域产生巨大的影响,为个性化医学开辟新的前景。本研究讨论了这些影响。